|
ACC Biotech manages the investments in the biotechnology industry. We focus our investments in companies working for the development of stem cell technologies such as BrainStorm Cell Therapeutics (OTC BB: BCLI), for which we are the majority shareholder.  Brainstorm is a leader in the research and development for stem cell technologies. The company's technology is based on retrieval of adult cells from the bone marrow, separated and expanded and then implants the NTF (Neurotrophic Secreted cells) into the damaged area. The company is currently targeting Parkinson’s, ALS (Lou Gehrig’s disease), and spinal cord injuries. Through investments such as this one, we hope to find a cure for people suffering with neurodegenerative diseases. |
Subsidiaries 
